Teladoc Health, Inc. (NYSE:TDOC) Q3 2024 Earnings Conference Call October 30, 2024 4:30 PM ET

Company Participants

Michael Minchak - Head of Investor Relations
Chuck Divita - Chief Executive Officer
Mala Murthy - Chief Financial Officer

Conference Call Participants

Stephanie Davis - Barclays
Lisa Gill - JPMorgan
Jessica Tassan - Piper Sandler
Michael Cherny - Leerink Partners
Sean Dodge - RBC Capital Markets
Sarah James - Cantor Fitzgerald
Jailendra Singh - Truist Securities
Richard Close - Cannacord
Glen Santangelo - Jefferies
Charles Rhyee - TD Cowen
Allen Lutz - Bank of America
Sameer Patel - Evercore ISI

Operator

Hello, and welcome to the Teladoc Health Third Quarter 2024 Call. My name is Alex, and I'll be coordinating the call today. [Operator Instructions]

I'll now hand over to your host, Michael Minchak, Head of Investor Relations. Please go ahead.

Michael Minchak

Thank you, and good afternoon. Today, after the market closed, we issued a press release announcing our third quarter 2024 financial results. This press release and the accompanying slide presentation are available in the Investor Relations section of the teladochealth.com website.

On this call to discuss the results are Chuck Divita, Chief Executive Officer; and Mala Murthy, Chief Financial Officer. During this call, we will also discuss our outlook and our prepared remarks will be followed by a question-and-answer session.

Please note that we will be discussing certain non-GAAP financial measures that we believe are important in evaluating Teladoc Health's performance. Details on the relationship between these non-GAAP measures to the most comparable GAAP measures and reconciliations thereof can be found in the press release that is posted on our website.

Also, please note that certain statements made during this call will be forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks, uncertainties and other factors that could cause the actual results for Teladoc Health to differ materially from those expressed or implied on this call. For additional information, please refer to our cautionary statement on our press release and our filings with the SEC all of which are available on our website.

I would now like to turn the call over to Chuck.

Chuck Divita

Thanks, Mike, and good afternoon, everyone.

We're pleased with our results for the quarter, including delivering Integrated Care revenue, adjusted EBITDA and membership above guidance, as well as BetterHelp revenue in line with prior commentary. Mala will provide more detail on our results in a moment.